Related references
Note: Only part of the references are listed.Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition)
Eishi Baba et al.
GASTRIC CANCER (2023)
Patterns of Adjuvant Chemotherapy Use and Association With Survival in Adults 80 Years and Older With Pancreatic Adenocarcinoma
Winta T. Mehtsun et al.
JAMA ONCOLOGY (2022)
Gastric Cancer in Older Patients: A Retrospective Study and Literature Review
Yonghoon Choi et al.
ANNALS OF GERIATRIC MEDICINE AND RESEARCH (2022)
Chemotherapy for Metastatic Gastric Cancer: Does Age Matter? A Single-Center, Retrospective, Real-World Study
Po-Wei Liao et al.
CLINICAL MEDICINE INSIGHTS-ONCOLOGY (2022)
Survival analysis of elderly patients over 65 years old with stage II/III gastric cancer treated with adjuvant chemotherapy after laparoscopic D2 gastrectomy: a retrospective cohort study
Yanrui Liang et al.
BMC CANCER (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
The prognostic role of platelet-to-lymphocyte ratio on overall survival in gastric cancer: a systematic review and meta-analysis
Weijuan Cao et al.
BMC GASTROENTEROLOGY (2020)
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
Salah-Eddin Al-Batran et al.
LANCET (2019)
The Epidemiology of Gastric Cancers in the Era of Helicobacter pylori Eradication: A Nationwide Cancer Registry-Based Study in Taiwan
Jeffrey S. Chang et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2019)
Adjuvant Chemotherapy for Advanced Gastric Cancer in Elderly and Non-elderly Patients: Meta-Analysis of Randomized Controlled Trials
Seong-Hwan Chang et al.
CANCER RESEARCH AND TREATMENT (2017)
Management of Stage III Colon Cancer in the Elderly: Practice Patterns and Outcomes in the General Population
Shaila J. Merchant et al.
CANCER (2017)
A High Lymph Node Yield is Associated with Prolonged Survival in Elderly Patients Undergoing Curative Gastrectomy for Cancer: A Dutch Population-Based Cohort Study
Hylke J. F. Brenkman et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Lymphadenectomy in elderly/high risk patients: should it be different?
Laura Ruspi et al.
TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY (2017)
Can the Neutrophil to Lymphocyte Ratio Be Used to Determine Gastric Cancer Treatment Outcomes? A Systematic Review and Meta-Analysis
Jingxu Sun et al.
DISEASE MARKERS (2016)
Extended lymphadenectomy in elderly and/or highly co-morbid gastric cancer patients: A retrospective multicenter study
S. Rausei et al.
EJSO (2016)
Adjuvant chemotherapy for elderly patients (aged 70 or older) with gastric cancer after a gastrectomy with D2 dissection: A single center experience in Korea
Jae-Cheol Jo et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2015)
Cancer-related inflammation and treatment effectiveness
Connie I. Diakos et al.
LANCET ONCOLOGY (2014)
Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial
Sung Hoon Noh et al.
LANCET ONCOLOGY (2014)
Adjuvant Chemotherapy for Elderly Patients with Gastric Cancer after D2 Gastrectomy
Ying Jin et al.
PLOS ONE (2013)
Characteristics and prognosis of gastric cancer in patients aged ≥ 70 years
Yue-Xiang Liang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Adjuvant therapy for elderly patients with resected gastric adenocarcinoma Population-Based Practices and Treatment Effectiveness
Karen E. Hoffman et al.
CANCER (2012)
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2012)
Guideline Recommended Gastric Cancer Care in the Elderly: Insights into the Applicability of Cancer Trials to Real World
Vikas Dudeja et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer
Mitsuru Sasako et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial
Ilfet Songun et al.
LANCET ONCOLOGY (2010)
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
David Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Gastric cancer-patterns of relapse after surgical resection
LL Gunderson
SEMINARS IN RADIATION ONCOLOGY (2002)
Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.
JS Macdonald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
